ConductScience.org, home

Paper36968618

Drug-induced liver injury: a comprehensive review.

Hosack T and 2 others. Ther Adv Gastroenterol, 2023. Cited by 160 papers, by iCite.

Cite this record

ConductScience Library. Drug-induced liver injury: a comprehensive review. Papers, record 36968618. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36968618

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Drug-induced liver injury: a comprehensive review.
PubMed
Journal
Ther Adv Gastroenterol
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
160
iCite
Relative citation ratio, by iCite
24.5
iCite
Revised in PubMed
2023-03-28
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hosack TTom
2Damry DDjamil
3Biswas SSujatahttps://orcid.org/0000-0002-0700-7286

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References73

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
122855883FDA summary of adverse events on electronic cigarettes.Nicotine Tob Res2013https://conductscience.org/library/papers/22855883PubMed
235656297N-Acetylcysteine for the Management of Non-Acetaminophen Drug-Induced Liver Injury in Adults: A Systematic Review.Front Pharmacol2022https://conductscience.org/library/papers/35656297PubMed
311866484Drug metabolism and drug interactions in the elderly.Best Pract Res Clin Gastroenterol2001https://conductscience.org/library/papers/11866484PubMed
429853659Diagnosis and Management of Hepatitis in Patients on Checkpoint Blockade.Oncologist2018https://conductscience.org/library/papers/29853659PubMed
58229111Causality assessment of adverse reactions to drugs--II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge.J Clin Epidemiol1993https://conductscience.org/library/papers/8229111PubMed
628370205FABP1 as a novel potential biomarker for predicting mortality in acetaminophen-induced acute liver failure.Hepatology2017https://conductscience.org/library/papers/28370205PubMed
735243675Letter to the editor: Electronic RUCAM: Major pitfalls call for caution and proper validation.Hepatology2022https://conductscience.org/library/papers/35243675PubMed
831892250Diagnostic Biomarkers in Liver Injury by Drugs, Herbs, and Alcohol: Tricky Dilemma after EMA Correctly and Officially Retracted Letter of Support.Int J Mol Sci2019https://conductscience.org/library/papers/31892250PubMed
927224670Elevated levels of circulating CDH5 and FABP1 in association with human drug-induced liver injury.Liver Int2017https://conductscience.org/library/papers/27224670PubMed
1019475693Phenotypic characterization of idiosyncratic drug-induced liver injury: the influence of age and sex.Hepatology2009https://conductscience.org/library/papers/19475693PubMed
1128782153N-acetylcysteine and prednisolone treatment improved serum biochemistries in suspected flupirtine cases of severe idiosyncratic liver injury.Liver Int2018https://conductscience.org/library/papers/28782153PubMed
1228379596Liver transplantation for drug-induced acute liver failure.Eur Rev Med Pharmacol Sci2017https://conductscience.org/library/papers/28379596PubMed
1319826967Epidemiology of idiosyncratic drug-induced liver injury.Semin Liver Dis2009https://conductscience.org/library/papers/19826967PubMed
1430022949Proteomics Analysis of Monocyte-Derived Hepatocyte-Like Cells Identifies Integrin Beta 3 as a Specific Biomarker for Drug-Induced Liver Injury by Diclofenac.Front Pharmacol2018https://conductscience.org/library/papers/30022949PubMed
1532768244Best practices for detection, assessment and management of suspected immune-mediated liver injury caused by immune checkpoint inhibitors during drug development.J Autoimmun2020https://conductscience.org/library/papers/32768244PubMed
1628440304The Natural History of Severe Acute Liver Injury.Am J Gastroenterol2017https://conductscience.org/library/papers/28440304PubMed
1722931300Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.Chem Res Toxicol2012https://conductscience.org/library/papers/22931300PubMed
1811172350A model to predict survival in patients with end-stage liver disease.Hepatology2001https://conductscience.org/library/papers/11172350PubMed
1912143055Incidence of drug-induced hepatic injuries: a French population-based study.Hepatology2002https://conductscience.org/library/papers/12143055PubMed
208229110Causality assessment of adverse reactions to drugs--I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries.J Clin Epidemiol1993https://conductscience.org/library/papers/8229110PubMed

See all 73 referencesDownload CSV of references

Cited by113

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 160 citations.

PMIDTitleJournalYearIn PapersSource
42920164Epinephrine-mediated sensitization of thioredoxin 1 enhances chlorpromazine protection against acute hepatotoxicity.BMC Pharmacol Toxicol2026https://conductscience.org/library/papers/42920164PubMed
42901497Hepatic Cysts in Korea: Prevalence, Incidence, and Risk Factors Based on a 5.8-Year Follow-up Health Screening Cohort.J Korean Med Sci2026https://conductscience.org/library/papers/42901497PubMed
42856423High-Throughput Morphological Profiling of Patient-Derived Human Liver Organoids for Hepatotoxicity Hazard Identification and Compound Prioritization.bioRxiv2026https://conductscience.org/library/papers/42856423PubMed
42840333A pharmacist-led framework for antibiotic-associated liver injury: from pharmacovigilance signals to bedside surveillance with the updated RUCAM and susceptibility markers.Front Pharmacol2026https://conductscience.org/library/papers/42840333PubMed
42830472A multiparametric in vitro strategy for small molecule drug-induced liver injury risk mitigation in early drug development.Toxicol Sci2026https://conductscience.org/library/papers/42830472PubMed
42805974Risk of drug-induced liver injury in multiple system atrophy patients treated with KM-819 is potentially associated with the HLA-DPB1*05:01:01:01 allele.Pharmacogenomics J2026https://conductscience.org/library/papers/42805974PubMed
42797383Computational Prediction of the Severity of Adverse Drug Reactions Caused by Drug-Drug Interactions.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42797383PubMed
42768705Drug-Induced Liver Injury During Treatment With Tocilizumab: A Case Report of an Atypical Pattern Lesion.Pharmacol Res Perspect2026https://conductscience.org/library/papers/42768705PubMed
42731995In vitro approaches for modelling gut-liver crosstalk in drug-induced liver injury.Arch Toxicol2026https://conductscience.org/library/papers/42731995PubMed
42652215Dietary, Nutrient, and Supramolecular Nanofiber Modulation of the Liver Sinusoidal Clearance System in Metabolic Diseases and Aging.Biomedicines2026https://conductscience.org/library/papers/42652215PubMed
42639177Precision treatment and frontier advances of glycyrrhizin preparations in drug-induced liver injury (DILI).Front Pharmacol2026https://conductscience.org/library/papers/42639177PubMed
42591220
Polygonatum odoratum extract ameliorates acetaminophen-induced acute liver injury by modulating the gut-liver axis and remodeling microbial and ceramide metabolism to suppress hepatic ferroptosis: insights from multi-omics.
Front Pharmacol2026https://conductscience.org/library/papers/42591220PubMed
42587752Rapid Volumetric Bioprinting Coupled with Dynamic Perfusion Enhances Human Hepatic Organoid Toxicity Testing.Cells2026https://conductscience.org/library/papers/42587752PubMed
42582612RUCAM-ascertained immunology and autoimmunity specifics of six idiosyncratic drug-induced liver injury types with refined classification: their individual complex molecular interplay.Front Immunol2026https://conductscience.org/library/papers/42582612PubMed
42524294Stepwise design and synthesis of red-emitting, reversible, HOCl chemosensors for monitoring the progression of drug-induced liver injury.RSC Adv2026https://conductscience.org/library/papers/42524294PubMed
42512832Etiology-Based Comparative Evaluation of Toxic Hepatitis in a Tertiary Referral Cohort: Drug-Induced, Herb-Induced, Mushroom Poisoning, and Other Toxic Exposures.Medicina (Kaunas)2026https://conductscience.org/library/papers/42512832PubMed
42442117Targeted degradation of hepatic KEAP1 mitigates drug-induced liver injury via dual boosting NRF2 and PGAM5 signaling.Redox Biol2026https://conductscience.org/library/papers/42442117PubMed
42419714Context-Aware Multilevel Classification of Semantic Relations in Drug-Adverse Drug Reaction (ADR) Networks-Predicting Drug-Induced Liver Injury (DILI) as a Case Study.Chem Res Toxicol2026https://conductscience.org/library/papers/42419714PubMed
42257007Meropenem-Induced Possible Mixed Drug-Induced Liver Injury With Cholestatic Evolution: A Case Report Evaluated Using the Updated RUCAM (2016).Clin Case Rep2026https://conductscience.org/library/papers/42257007PubMed
42244311[Differences in the mechanisms, diagnostic biomarkers, and therapeutic strategies of drug-induced liver injury caused by traditional Chinese and Western medicines].Zhong Nan Da Xue Xue Bao Yi Xue Ban2026https://conductscience.org/library/papers/42244311PubMed

See all 113 cited byDownload CSV of cited by

Genes13

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36968618

GET https://conductscience.org/api/papers/v1/36968618/references?page=2